Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Down's syndrome (DS) or trisomy 21 is the most common genetic cause of mental retardation. Development of the DS brain is associated with decreased neuronal number and abnormal neuronal differentiation, and adults with DS develop Alzheimer's disease. The cause of the neurodegenerative process in DS is unknown. Here we report that cortical neurons from fetal DS and age-matched normal brain differentiate normally in culture, but DS neurons subsequently degenerate and undergo apoptosis whereas normal neurons remain viable. Degeneration of DS neurons is prevented by treatment with free-radical scavengers or catalase. Furthermore, DS neurons exhibit a three- to fourfold increase in intracellular reactive oxygen species and elevated levels of lipid peroxidation that precede neuronal death. These results suggest that DS neurons have a defect in the metabolism of reactive oxygen species that causes neuronal apoptosis. This defect may contribute to mental retardation early in life and predispose to Alzheimer's disease in adults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Other biomarkers of increased oxidative damage in the brains of persons with DS and persons with DS with AD neuropathology (DS with AD) include elevated levels of HNE and PC15,42; the increases are greater in people with DS with AD62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“These oxidatively modified, and likely dysfunctional, proteins include ones associated with altered glucose metabolism, mTOR signaling (including inhibited autophagy and increased insulin resistance), and the proteostasis network42,61,62,65,66.”
From Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease (2019) · cites this paper as [62]
In the citing paper
“Analysis of such cortical neurons from fetuses, confirmed significantly increased levels of ROS responsible for apoptosis (Busciglio and Yanker 1995).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Busciglio and Yanker 1995
Citations
Cites
Cell Death: The Significance of Apoptosis
Wyllie, A. H., Kerr, J. F. R., & Currie, A. R. (1980) · International Review of Cytology · doi:10.1016/s0074-7696(08)62312-8 · Cited by 7,162
Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C., & Thomas, M. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.4.1910 · Cited by 1,809
Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species
Kane, D., Sarafian, T., Anton, R., Hahn, H., Gralla, E., Valentine, J., Ord, T., & Bredesen, D. (1993) · Science · doi:10.1126/science.8235659 · Cited by 1,671
Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease.
Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., & Markesbery, W. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.23.10540 · Cited by 1,296
Royall, J. A., & Ischiropoulos, H. (1993) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1993.1222 · Cited by 1,119
Oxidative damage to mitochondrial DNA is increased in Alzheimer’s disease
Mecocci, P., MacGarvey, U., & Beal, M. F. (1994) · Annals of Neurology · doi:10.1002/ana.410360510 · Cited by 1,037
Detection of picomole levels of hydroperoxides using a fluorescent dichlorofluorescein assay
Cathcart, R., Schwiers, E., & Ames, B. N. (1983) · Analytical Biochemistry · doi:10.1016/0003-2697(83)90270-1 · Cited by 852
Greenlund, L. J. S., Deckwerth, T. L., & Johnson, E. M. (1995) · Neuron · doi:10.1016/0896-6273(95)90287-2 · Cited by 742
Programmed cell death and Bcl-2 protection in very low oxygen
Jacobson, M. D., & Raff, M. C. (1995) · Nature · doi:10.1038/374814a0 · Cited by 625
Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
Shimizu, S., Eguchi, Y., Kosaka, H., Kamiike, W., Matsuda, H., & Tsujimoto, Y. (1995) · Nature · doi:10.1038/374811a0 · Cited by 611
Research works printed but not linked: 1
- Becker, L., Mito, T., Takashima, S. & Onodera, K. Prog. clin. biol. Res. 373, 133–152 (1991).
Cited by
Items 601–700 of 749
Advances in Research on Down Syndrome
Dey, S. (2018) · InTech eBooks · doi:10.5772/intechopen.68260 · Cited by 7
Cao, G.-J., Chen, Y., Chen, X., Weng, P., & Lin, R. (2019) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2019.1555319 · Cited by 7
Alzheimer’s Disease-related Biomarkers in Aging Adults with Down Syndrome: Systematic Review
Bram, J. M. D. F., Talib, L. L., Joaquim, H. P. G., Carvalho, C. L., Gattaz, W. F., & Forlenza, O. V. (2019) · Current Psychiatry Research and Reviews · doi:10.2174/1573400515666190122152855 · Cited by 9
Toshikawa, H., Ikenaka, A., Li, L., Nishinaka‐Arai, Y., Niwa, A., Ashida, A., Kazuki, Y., Nakahata, T., Tamai, H., Russell, D. W., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-96697-7 · Cited by 7
Oxidative Stress and Periodontal Disease in Down Syndrome
Komatsu, T., & Lee, M. (2013) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4614-9557-4_15 · Cited by 7
“Various studies have indicated that SOD plays an important role in both DS and AD, which is consistent with the notion that oxidative stress underlies these disorders and serves as a necessary insult for initiation and progression of the disease [ 3 ].”
BackgroundInfluentialMethylation of cortical brain proteins from patients with HIV infection
Goggins, M., Scott, J. M., & Weir, D. G. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1999.tb00405.x · Cited by 7
Extensive Natural Variation for Cellular Hydrogen Peroxide Release Is Genetically Controlled
Attar, H., Bedard, K., Migliavacca, E., Gagnebin, M., Dupré, Y., Descombes, P., Borel, C., Deutsch, S., Prokisch, H., Meitinger, T., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043566 · Cited by 6
“However, the role, impact, and consequences of low or high ROS levels in various cell types of this chromosomal abnormality remain obscure [35–39].”
BackgroundEngidawork, E., Roberts, J. C., Hardmeier, R., Scheper, R. J., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_3 · Cited by 6
Pulmonary Epithelial Apoptosis in Fetal down Syndrome: Not Higher than Normal
Bruijn, M., von der Thüsen, J. H., van der Loos, C. M., de Krijger, R. R., van Loenhout, R. B., Bos, A. P., & van Woensel, J. B. M. (2012) · Pediatric and Developmental Pathology · doi:10.2350/11-08-1080-oa.1 · Cited by 6
“High levels of apoptosis and of proapoptotic proteins have been found in adult but not in fetal DS brains [19–22].”
BackgroundChen, C., Ringenbach, S. D. R., & Nam, K. (2021) · Journal of Developmental and Physical Disabilities · doi:10.1007/s10882-021-09786-w · Cited by 6
“Down syndrome, caused by an extra 21st chromosome, is one of the most common genetic diseases in human society (Busciglio and Yankner 1995).”
BackgroundOlder Adults with Intellectual Disabilities: Issues in Ageing and Dementia
Kalsy, S., Adams, D., & Oliver, C. (2012) · Wiley eBooks · doi:10.1002/9781118404898.ch17 · Cited by 6
Risk Factors for Alzheimer's Disease in Down Syndrome
Ward, L. (2004) · International review of research in mental retardation · doi:10.1016/s0074-7750(04)29005-x · Cited by 7
Cell Cycle and Chromosome Segregation Defects in Alzheimer’s Disease
Potter, H. (2005) · Springer eBooks · doi:10.1007/0-387-29390-6_5 · Cited by 7
Potential therapeutic targets for Alzheimer’s disease
McKeon‐O'Malley, C., Saunders, A. J., Bush, A. I., & Tanzi, R. E. (1998) · Emerging Therapeutic Targets · doi:10.1517/14728222.2.2.157 · Cited by 8
Vujovic, F., Shepherd, C. E., Witting, P. K., Hunter, N., & Farahani, R. H. (2023) · Antioxidants · doi:10.3390/antiox12101873 · Cited by 7
“In a parallel situation, patients with Down syndrome who are predisposed to early onset AD [219] exhibit significantly higher levels of oxidative stress despite a lack of senile plaques and neurofibrillary tangles [220,221].”
BackgroundThe elevated proinsulin-to-insulin ratio is associated with oxidative stress in Down's syndrome
Available, N. A. N. (2001) · Diabetologia · doi:10.1007/s001250051692 · Cited by 5
Ageing, Dementia and People with Intellectual Disability
Oliver, C., Adams, D., & Kalsy, S. (2008) · Wiley eBooks · doi:10.1002/9780470773185.ch20 · Cited by 5
Nonlinear Optics in Doped Silica Glass Integrated Waveguide Structures
Duchesne, D., Ferrera, M., Razzari, L., Morandotti, R., Little, B. E., Sai, T., & David, J. (2010) · InTech eBooks · doi:10.5772/39556 · Cited by 6
Potential risk factors for developing apoptosis during septic shock
Denlinger, L. C., & Proctor, R. A. (2000) · Critical Care Medicine · doi:10.1097/00003246-200006000-00080 · Cited by 5
The Antiapoptotic Effect of Low-dose UVB Irradiation in NIH3T3 Cells Involves Caspase Inhibition¶
Ibuki, Y., & Goto, R. (2003) · Photochemistry and Photobiology · doi:10.1562/0031-8655(2003)0770276taeold2.0.co2 · Cited by 6
“Furthermore, lipid peroxidation (12,13), production”
Therapeutic Strategies in Alzheimer’s Disease
Beal, M. F. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_49 · Cited by 5
“A recent study demonstrated that neurons cultured from Down's syndrome fetal tissue show increased cell death by an apoptotic mechanism between 7 and 14 days in culture, whereas normal neurons can be cultured up to 100 days (Busciglio and Yankner, 1995).”
BackgroundDevelopment of Alzheimer’s disease in Down syndrome
García, O. A., Domínguez-de-la-Cruz, E., Luna-Martínez, I. G., Garnett-Carbajal, J. A., & Villegas-Piña, J. A. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.1006104 · Cited by 4
Down Syndrome: A Complex and Interactive Genetic Disorder
Samantha, L., Joshua, D., Jeffrey, P. D., & Randall, J. (2011) · InTech eBooks · doi:10.5772/18436 · Cited by 4
“A disproportionate number of ROS, caused by mitochondrial and other changes, combined with altered metabolism and feedback mechanisms suggest the complexity of the interacting mechanisms involved in DS phenotypes affecting the brain, heart and skin (Busciglio and Yankner, 1995; Li et al., 2006; Sinha, 2005).”
BackgroundChanges in nuclear receptor corepressor RIP140 do not influence mitochondrial content in the cortex
Herbst, E. A. F., Bonen, A., & Holloway, G. P. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0192 · Cited by 4
Combinatorial Gene Effects on the Neural Progenitor Pool in Down Syndrome
Lu, J., & Shee, V. (2011) · InTech eBooks · doi:10.5772/20888 · Cited by 6
“1 Mitochondrial dysfunction and apoptosis Oxidative stress is increased in DS brain and the imbalance of reactive oxygen species (ROS) metabolism may be the key component giving rise to DS pathogenesis- namely neuronal degeneration (Brooksbank and Balazs, 1984; Busciglio and Yankner, 1995).”
Io, I., Osinubi, A., Saalu, L. C., & Olagunju, J. A. (2011) · International Journal of Biological and Chemical Sciences · doi:10.4314/ijbcs.v4i6.64974 · Cited by 4
The Thymus/Neocortex Hypothesis of the Brain: A Cell Basis for Recognition and Instruction of Self
Sánchez‐Ramón, S., & Faure, F. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00340 · Cited by 5
“By contrast, abnormally high rate of apoptosis is generally associated with neurodegenerative diseases (Down syndrome, Alzheimer disease, Huntington disease, dementia) (Busciglio and Yankner, 1995; Arendt, 2001; Hyman and Yuan, 2012).”
BackgroundRamotar, D., & Nepveu, A. (2018) · Journal of Radiation and Cancer Research · doi:10.4103/jrcr.jrcr_8_18 · Cited by 4
Dutta, S., Prashanth, K. H. P., Ramesh, N., & Middha, S. K. (2022) · Plant Science Today · doi:10.14719/pst.1705 · Cited by 4
“Reactive oxygen species (ROS) cause oxidative damage and may speed up the progression of diseases such as ageing, arthritis, cancer and heart disease (3, 4).”
BackgroundAberrant Chromosome 21 Gene Products: Explaining the Down Syndrome Phenotype?
Ferrando-Miguel, R., Cheon, M. S., & Lübec, G. (2004) · Neuroembryology and Aging · doi:10.1159/000085398 · Cited by 4
Soichiro, A. R. A. I., Itoh, H., Kanda, S., Endoh, D., & Hayashi, M. (2000) · Journal of Veterinary Medical Science · doi:10.1292/jvms.62.43 · Cited by 4
“Antioxidants, such as N-acetylcysteine [11], N-tert-butyl-2sulphophenylnitrone [4], WR-1065 [18], vitamin E analogs [8, 15, 19], ascorbic acid (vitamin C) [14], and glutathion peroxidase [11], inhibit apoptosis to varying extents dependent on the biological system.”
BackgroundCerebral Zinc Metabolism in Alzheimer’s Disease
Atwood, C., Moir, R. D., Huang, X., Tanzi, R. E., & Bush, A. I. (1997) · Humana Press eBooks · doi:10.1007/978-1-59259-471-9_14 · Cited by 4
Levman, J. E. D. (2025) · Biology · doi:10.3390/biology14121651 · Cited by 3
“It should be noted that it has been reported that DS patients exhibit increased rates of apoptosis [89,90], including a mix of increases and decreases in apoptosis-linked proteins [89], potentially implying a dysregulation of natural apoptosis and pruning in the DS brain, possibly contributing to…”
Alamgir, H., Mahbub, S., Ahmed, M., & Kayser, M. S. (2016) · European Journal of Medicinal Plants · doi:10.9734/ejmp/2016/22160 · Cited by 6
Lithium restores nuclear REST and Mitigates oxidative stress in down syndrome iPSC-Derived neurons
Lam, X.-J., Maniam, S., Ling, K., & Cheah, P.-S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2024.12.061 · Cited by 3
Mitochondrial Abnormalities in Down Syndrome: Pathogenesis, Effects and Therapeutic Approaches
Izzo, A., Mollo, N., Cicatiello, R., Genesio, R., Paladino, S., Conti, A. M. F., & Nitsch, L. (2018) · InTech eBooks · doi:10.5772/intechopen.71059 · Cited by 4
“Development of the DS brain is associated with decreased neuronal number and abnormal neuronal differentiation [78].”
BackgroundPeripheral Oxidation Markers in Down Syndrome Patients: The Better and the Worse
Szwajgier, D., Baranowska‐Wójcik, E., Grzelczyk, J., & Żukiewicz-Sobczak, W. A. (2021) · Disease Markers · doi:10.1155/2021/5581139 · Cited by 3
“, in a work of Busciglio and Yankner [2] and the excellent reviews by Barone et al.”
BackgroundLioudyno, M., Sevrioukov, E. A., Olivarria, G. M., Hitchcock, L., Javonillo, D. I., Campos, S. M., Rivera, I., Wright, S. T., Head, E., Fortea, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02895-2 · Cited by 3
“…human cortical cultures were established from 12 EUPL (9 XX, 3 XY) and 6 T21 (2 XX, 4 XY) post-mortem fetal specimens of the cerebral cortex procured at 15–20 weeks of gestation and according to previously published protocol [18, 19, 59, 63, 73, 138] with minor modifications as described below.”
Self-citationGlozman, S., Cerruti-Harris, C., Groner, Y., & Yavin, E. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00085-8 · Cited by 3
Wpływ stresu oksydacyjnego na przebieg kliniczny ostrych białaczek mieloblastycznych
Jawniak, D., Jawniak, R., Małek, M., & Górska‐Ponikowska, M. (2004) · Reports of Practical Oncology & Radiotherapy · doi:10.1016/s1507-1367(04)71022-6 · Cited by 3
Resistin in mid-trimester amniotic fluid in trisomy 21
Vrachnis, N., Gkogkas, L., Iliodromiti, S., Grigoriadis, C., Samoli, E., Iliodromiti, Z., Pángalos, C., Pappa, K. I., Drakoulis, N., Creatsas, G. K., et al. (2013) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2013.789848 · Cited by 3
“Trisomy 21 has been suggested as being linked with oxidative stress processes in fetal [23] and later adult life [24].”
BackgroundHeart Failure in Pediatric Oncologic Disease
Bansal, N., Venkata, J. A., Franco, V. I., & Lipshultz, S. E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-802393-8.00032-6 · Cited by 3
All-Optical Wavelength-Selective Switch by Intensity Control in Cascaded Interferometers
Kishikawa, H., Goto, N., & Kimiy, K. (2010) · InTech eBooks · doi:10.5772/39555 · Cited by 3
Down Syndrome Model of Alzheimer’s Disease: Beyond Trisomy 21Nondisjunction
Granic, A., & Potter, H. (2011) · InTech eBooks · doi:10.5772/24948 · Cited by 3
Yin, D. L., Ren, X. H., Bu, S. Z., Wu, Y. L., Li, J., Wu, Z. J., Hu, W., & Pei, G. (1996) · Cell Research · doi:10.1038/cr.1996.15 · Cited by 3
“It could be speculated that several parallel pathways may be involved in the regulation of apoptosis in macrophage Ana-1 cells, as depicted in other types of cells[23-29], and the interactions of these apoptotic pathways result in the complicated pattern of bcl-2 expression.”
BackgroundRole of Apoptosis in Neurotoxicology
White, L. D., Hunter, S., Miller, M. W., Ehrich, M. F., & Barone, S. (2004) · Humana Press eBooks · doi:10.1385/1-59259-651-7:95 · Cited by 3
Torres, M. D., & Busciglio, J. A. (2014) · Springer eBooks · doi:10.1007/978-3-7091-0715-7_10 · Cited by 2
Self-citationEl péptido β-amiloide: mecanismos de neurotoxicidad. neuroprotección por antioxidantes y estrógenos
López, F. J. M. (2001) · Revista Española de Geriatría y Gerontología · doi:10.1016/s0211-139x(01)74694-x · Cited by 5
“e) Las células neuronales de individuos con trisomía 21 presentan evidencias de un extendido daño oxidativo (58).”
Radicais Livres e Neurodegeneração
Pôrto, W. G. (2019) · Revista Neurociências · doi:10.34024/rnc.2001.v9.8922 · Cited by 2
Terapias complementarias y alternativas para el síndrome de Down
Roizen, N. (2005) · Americanae (AECID Library) · Cited by 2
Urinary Hydrogen Peroxide as Biomarker
Wang, D.-H., Ogino, K., Sato, Y., Sakano, N., Kubo, M., Takemoto, K., & Masatomi, C. (2015) · Biomarkers in disease · doi:10.1007/978-94-007-7696-8_43 · Cited by 4
The Bcl-2 family of proteins and their actions within the molecular machinery of cell death
Guo, Q., Chan, S. L., & Kruman, I. I. (2001) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(01)05006-4 · Cited by 3
Gene Hunting by Substractive Hybridization in Down Syndrome Correlation with Proteomics Analysis
Golubnitschaja, O., & Fountoulakis, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_16 · Cited by 4
Brown, S. (2002) · Wiley eBooks · doi:10.1002/9780470776216.ch7 · Cited by 2
Stress oxydant et maladie d’Alzheimer
Gilbert, T., Drai, J., & Bonnefoy, M. (2013) · Springer eBooks · doi:10.1007/978-2-8178-0443-9_10 · Cited by 2
Antioxidant Genes and Reactive Oxygen Species in Down's Syndrome
Bladier, C., de Haan, J. B., & Kola, I. (2000) · Elsevier eBooks · doi:10.1016/b978-012636670-9/50021-0 · Cited by 2
McNeill, A. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0457-5 · Cited by 2
Synaptic and Neuroglial Pathobiology in Acute and Chronic Neurological Disorders
Martin, L. J. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-105-3_25 · Cited by 1
Sato, T., Baxter, L. L., Adams, A. D., Bishop, L. A., Guedj, F., & Bianchi, D. W. (2025) · Biology Open · doi:10.1242/bio.062296 · Cited by 1
“Several studies suggest oxidative stress is increased in individuals with DS during prenatal development (Buczyn ́ ska et al., 2021; Busciglio and Yankner, 1995; Perluigi and Butterfield, 2012; Slonim et al., 2009).”
Plećaš, A., Gough, G., Grčević, D., Jackowiak, H., Skieresz‐Szewczyk, K., Horaček, M., Šimunić, I., Krsnik, Ž., Mitrečić, D., Murray, A., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-08956-y · Cited by 1
Cancer among Persons with Down Syndrome
Hitzler, J. K. (2010) · International review of research in mental retardation · doi:10.1016/s0074-7750(10)39005-7 · Cited by 1
Skeletal Muscle Function, Morphology, and Biochemistry in Ts65Dn Mice: A Model of Down Syndrome
Cowley, P. M. (2011) · Syracuse University Libraries (Syracuse University) · Cited by 1
Škorvaga, M., Durdík, M., Košík, P., Markovà, E., Holop, M., Kubeš, M., Puškáčová, J., Kolenová, A., & Belyaev, I. Y. (2018) · Oncotarget · doi:10.18632/oncotarget.24976 · Cited by 1
Bowman, A. B., Ess, K. C., Kumar, K. K., & Summar, K. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397267-5.00130-8 · Cited by 1
Development of the brain and metabolism
Patterson, D. W. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511919299.007 · Cited by 1
Urinary Hydrogen Peroxide as Biomarker
Wang, D.-H., Ogino, K., Sato, Y., Sakano, N., Kubo, M., Takemoto, K., & Masatomi, C. (2014) · Springer eBooks · doi:10.1007/978-94-007-7740-8_43-1 · Cited by 1
REACTIVE OXYGEN SPECIES: A BOON OR BANE TO HUMAN HEALTH
Patnala, K. (2014) · International Research Journal of Pharmacy · doi:10.7897/2230-8407.0507111 · Cited by 1
Oxidative Stress in Down Syndrome: A Paradigm for the Pathogenesis of Neurodegenerative Disorders
Iannello, R. C., & Kola, I. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-106-0_7 · Cited by 1
Down Syndrome, Antioxidant Balance and the “Gene Dosage Effect” Hypothesis
de Haan, J. B., Crack, P. J., Pritchard, M. A., & Kola, I. (2007) · Elsevier eBooks · doi:10.1016/b978-044452809-4/50150-2 · Cited by 1
Perluigi, M., Domenico, F. D., & Butterfield, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818845-3.00009-8 · Cited by 1
Comments on Contemporary Methods of Oxygen and Nitrogen Free Radical Detection
(2005) · CRC Press eBooks · doi:10.1201/9781420030853.pt3 · Cited by 1
Ishihara, K. (2022) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.21-155 · Cited by 1
Imbalance in glutamatergic and GABAergic transmission in Down syndrome and therapeutic targets
Ganguly, B. B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90456-8.00007-7 · Cited by 1
Jones, D., Woods, E., Li, Z., Schaller, K., Hoffmeyer, E., Kooiman, B., Fernandez, J., Wharton, T., Tufa, D., Hall, S. C., et al. (2026) · Haematologica · doi:10.3324/haematol.2026.300808 · Cited by 1
Chapter 1 Genetic Contributions to the Pathogenesis of Alzheimer's Disease
Mattson, M. P. (1999) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60021-8 · Cited by 2
Weiner, C. P. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.12.028 · Cited by 1
Estresse oxidativo e envelhecimento
Poppe, S. C. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2019.tde-11032019-102753 · Cited by 1
The Role of Oxidative Imbalance in the Pathogenesis of Down Syndrome
Huang, T., Mantha, S., & Epstein, C. J. (2003) · Oxidative stress and disease · doi:10.1201/9780203912874.ch18 · Cited by 1
Miller, S. P., & Ferriero, D. M. (2007) · Elsevier eBooks · doi:10.1016/b978-012088592-3/50056-6 · Cited by 1
Lipids in Neurodegenerative Diseases
Yost, H., Patel, R., Kipp, A., & Reed, T. T. (2020) · Wiley eBooks · doi:10.1002/047167849x.bio115 · Cited by 1
Campbell, A., & Bondy, S. B. C. (2004) · Informa Healthcare eBooks · doi:10.1201/9780203503317.ch6 · Cited by 1
Campbell, A., & Bondy, S. C. (2004) · CRC Press eBooks · doi:10.1201/9780203503317-10
Enfermedad de Alzheimer y síndrome de Down
Flórez, J. (2006) · Revista Síndrome de Down: Revista española de investigación e información sobre el Síndrome de Down
Syndromes Due to Autosomal Deletions and Duplications
Miller, O. J., & Therman, E. (2001) · Springer eBooks · doi:10.1007/978-1-4613-0139-4_15
Granic, A. (2011) · Digital Commons - University of South Florida (University of South Florida)
Down Syndrome and Vascular Disease: DSCR1 and NFAT Signaling
Monica, Y., & Brian, R. (2011) · InTech eBooks · doi:10.5772/22449
“In vitro, DS neurons were observed to have 3- to 4-fold increases in reactive oxygen species compared to control cells, with elevated rates of consequent cell apoptosis (Busciglio & Yankner, 1995).”
Ibegbu, A. O., Fyfe, L., McBean, D. E., & Mullaney, I. (2012) · Journal of biological and environmental sciences
Synthesis of Azulenylsilane Nitrones as Diagnostic Tools for Superoxide Detection
Tamrakar, R. (2011) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fi11120906
Apoptosis, Part I: Biochemical assessment
Lam, C. W. K., & Wong, C. K. (2001) · Advances in clinical chemistry · doi:10.1016/s0065-2423(01)36025-0
Synthetic Studies of Azulenyl and Pseudoazulenyl Nitrones
Kolhe, A. (2009) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fi10022526
Lara, M. I. R. (2011) · Institutional Repository of the University of Granada (University of Granada)
Anàlisi molecular de gens implicats a la síndrome de Down
Font, S., & Francisca, M. (2002) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Wisniewski, K. E., Kida, E., Kuchna, I., Wierzba‐Bobrowicz, T., & Dambska, M. (1997) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-60861-2_11
Primary Mediastinal Neuroendocrine Carcinoma in a Child With Down Syndrome
Pathania, S., Thulkar, S. P., Ahuja, A., & Bakhshi, S. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23180
Ts65Dn: un modèle murin du syndrome de Down
Davisson, M. T., & Costa, A. C. S. (1998) · Annales de l Institut Pasteur / Actualités · doi:10.1016/s0924-4204(99)80011-0
Baich, A., Wanda, P. E., & Mitchell, M. D. (1997) · Pigment Cell Research · doi:10.1111/j.1600-0749.1997.tb00697.x
P4-197 Oxidative stress potentiates BACE1 gene expression and Aβ generation
Tong, Y., Zhou, W., Fung, V., Christensen, M. A., Qing, H., Sun, X., & Song, W. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(04)81755-x
“Down syndrome neurons show increase in intracellular reactive oxygen species and the defect in the metabolism of reactive oxygen species might cause neuronal apoptosis (Busciglio and Yankner, 1995).”
BackgroundApolipoproteins and β Amyloid Transport Pathway
Kamino, K., Kida, T., Tanaka, T., Tanii, H., Okochi, M., Kudo, T., Kobayashi, T., & Takeda, M. (2002) · Psychogeriatrics · doi:10.1111/j.1479-8301.2002.tb00078.x
Цветикова, Л. Н., Попова, Т. Н., Rakhmanova, T. I., & Iskusnykh, I. Y. (2010) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750810020101
Ibegbu, A. O., Mullaney, I., Fyfe, L., & MacBean, D. (2012) · International Journal of Human Genetics · doi:10.31901/24566330.2012/12.04.02
Metadata
- Authors
- Busciglio, J., & Yankner, B. A.
- Affiliations
- Boston Children's Hospital (US)
- Venue
- Nature
- Published
- 1995-12
- Volume
- 378
- Issue
- 6559
- Pages
- 776-779
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1992689843
- Cited by
- 741
- References
- 26
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 6 · 2023: 16 · 2022: 13 · 2021: 13 · 2020: 16 · 2019: 19 · 2018: 16 · 2017: 15 · 2016: 21 · 2015: 21 · 2014: 25 · 2013: 30 · 2012: 32
- FWCI
- 57.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- Down syndrome, neuronal apoptosis, reactive oxygen species, lipid peroxidation, cortical neurons, neurodegeneration, radical scavengers, catalase, Alzheimer's disease, intellectual disability, oxidative stress
- MeSH terms
- Alzheimer Disease, Antioxidants, Cell Differentiation, Cells, Cultured, Cerebral Cortex, Cycloheximide, Dactinomycin, Down Syndrome, Fluoresceins, Humans, Nerve Degeneration, Neurons, Lipid Peroxidation, Free Radical Scavengers, Apoptosis, Reactive Oxygen Species, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.